Overview

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Status:
Unknown status

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of apatinib as maintenance therapy after adjuvant chemotherapy in progressive gastric cancer patients with positive exfoliative cancer cells.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Hebei Medical University

Collaborator:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

Apatinib